TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search
PRESS RELEASES

TFF Pharmaceuticals Announces First Dosing Of Asthma Patients With Voriconazole Inhalation Powder In A Phase 1b Clinical Trial

PRESS RELEASES

TFF Pharmaceuticals To Present At The Jefferies Virtual London Healthcare Conference

PRESS RELEASES

TFF Pharmaceuticals And Felix Biotechnology Sign Letter Of Intent For A Collaboration, Development And License Agreement

PRESS RELEASES

TFF Pharmaceuticals, Inc. And Augmenta Bioworks, Inc. Enter Into A Worldwide Joint Development Agreement For COVID-19 Monoclonal Antibody Therapies

PRESS RELEASES

TFF Pharmaceuticals Announces Third Quarter 2020 Financial Results And Business Update Conference Call On November 5, 2020

PRESS RELEASES

TFF Pharmaceuticals Announces Positive Preclinical Results With University Of Georgia Universal Influenza Vaccines

PRESS RELEASES

TFF Pharmaceuticals Expands Its CGMP Manufacturing Capabilities With Experic

PRESS RELEASES

IRISYS LLC Signs A Third Contract With TFF Pharma To Produce Medication To Treat Lung Conditions, Including COVID-19

PRESS RELEASES

TFF Pharmaceuticals Comments On Animal Studies In The Development Of High Potency Remdesivir As A Dry Powder For Inhalation By Thin Film Freezing

PRESS RELEASES

TFF Pharmaceuticals To Participate In Anti-fungal Webinar Presented By Maxim Group LLC On September 17th, 2020

PRESS RELEASES

TFF Pharmaceuticals Enters Into Worldwide Licensing Agreement With UNION Therapeutics For Its Thin Film Freezing Technology In Combination With Niclosamide

PRESS RELEASES

TFF Pharmaceuticals Announces $25.9 Million In Financing To Further Advance Its Thin Film Freezing Technology Platform

PRESS RELEASES

TFF Pharmaceuticals Announces Second Quarter 2020 Financial Results And Business Update Conference Call On August 13, 2020

PRESS RELEASES

TFF Pharmaceuticals Announces Completion Of Dosing For Voriconazole Inhalation Powder Phase 1 Clinical Trial

PRESS RELEASES

TFF Pharmaceuticals Comments On Research On The Re-formulation Of Remdesivir To A Dry Powder Form For COVID-19 Antiviral Treatment

PRESS RELEASES

TFF Pharmaceuticals Announces First Human Dosing With Tacrolimus Inhalation Powder And Topline Data For Voriconazole Inhalation Powder

PRESS RELEASES

TFF Pharmaceuticals Receives Orphan Drug Designation For Tacrolimus Inhalation Powder

PRESS RELEASES

TFF Pharmaceuticals Announces First Quarter 2020 Financial Results And Business Update Conference Call On May 14, 2020

PRESS RELEASES

TFF Pharmaceuticals' Inventor Dr. Robert O. Williams III Presents Session On Repurposing Niclosamide For COVID-19 Treatment At AAPS Meeting

PRESS RELEASES

TFF Pharmaceuticals To Present At April 2020 Virtual Investor Summit

PRESS RELEASES

TFF Pharmaceuticals Announces Cooperative Research And Development Agreement (CRADA) With The United States Army Medical Research Institute Of Infectious Diseases (USAMRIID) For Use Of Its Thin Film Freezing Technology Platform

PRESS RELEASES

TFF Pharmaceuticals Announces R&D Collaboration With The University Of Georgia For A Universal Influenza Vaccine

PRESS RELEASES

TFF Pharmaceuticals Reschedules Fourth Quarter And Full-Year 2019 Financial And Business Results Conference Call For March 26, 2020 To 4:30 PM (EDT)

PRESS RELEASES

TFF Pharmaceuticals To Hold Fourth Quarter And Full-Year 2019 Financial And Business Results Conference Call On March 26, 2020